Condition: Acute Heart Failure (AHF) · Congestion, Venous · Sponsor: Wroclaw Medical University
The aim of this study is to evaluate the effectiveness of loop diuretic adaptative algorithm that is based on machine learning, urine output prediction tool, in decongestion of acute heart failure patients. A total of 90 patients will be enrolled in the study. Of these, 45 will be assigned to the algorithm-based intervention group, while the remaining 45 will serve as the control group. In the control group, all decisions regarding diuretic therapy will be made solely by the attending physician, without the use of the algorithm. Patients will receive intravenous furosemide, with the initial dose determined by the attending physician. Two hours after administration of the diuretic, a spot urine sample will be collected to measure sodium and creatinine concentrations. Based on these values, the 6-hour urine output will be estimated using the machine learning, urine output prediction tool (http://diuresis.umw.edu.pl). This estimate will guide the diuretic therapy plan for the first 24 hours of hospitalization. On the second day, the procedure will be repeated using the same methodology.
This description comes directly from the study's public registry record.
Jan Biegus, MD, PhD · 71 736 42 05 · jan.biegus@umw.edu.pl
Gracjan Iwanek, MD · 71 733 11 12 · gracjan.iwanek@student.umw.edu.pl
Always discuss trial participation with your own doctor first.
| Wroclaw Medical University | Wroclaw, Dolnosląskie, Poland | Recruiting |
| Wroclaw Medical University | Wroclaw, Lower Silesian Voivodeship, Poland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07099885